Dr. Gareth Brady
Ussher Assistant Professor, Clinical Medicine
My research career to date has been consistently focused on a strategy of using viruses to understand host immunity since I began post-graduate research, completing a PhD in 2005 on the investigation of novel immunoregulatory sequences in the genome of Vaccinia Virus with Professor Luke O'Neill (TCD). I then accepted a six month industrial placement in Opsona Therapeutics leading an independent project to establish several assays and reagents for screening anti-inflammatory compounds partially based on viral strategies of immune evasion and returned to academia.
In late 2006, I began a post-doctoral Leukemia and Lymphoma Research (LLRF) fellowship in the Section of Virology, Imperial College London with Professor Paul Farrell analyzing mechanisms of genetic cross-regulation during Epstein Barr Virus (EBV) immune evasion and discovered a complex regulatory control pathway manipulated by the virus to control Runx1 and Runx3 gene expression.
On completion of my EBV research, I wished to pursue a long-standing interest to begin research on the only known human-adapted poxvirus Molluscum Contagiosum Virus (MCV) which, despite the fact that the virus appeared incredibly adept at silencing local immunity and inflammation to go largely unnoticed during long term infections, had remained largely unexplored. To pursue this, I returned to Ireland on a Marie Curie career development IEF fellowship under the mentorship of Professor Andrew Bowie in Trinity College Dublin.
I became an Ussher Assistant Professor of Vascular Biology in Trinity College Dublin in 2017 and am continuing my research on inflammation signalling and my group is developing novel anti-inflammatory compounds using autoimmune vasculitis as a model for their activity. Additionally, my recent research involves developing seroassay tools for SARS-CoV2 and understanding both the immune response to this virus in COVID-19 and how the virus evades this response.
Publications and Further Research Outputs
Emma Leacy, Gareth Brady, Niall Conlon, Jennifer Scott, Jean Dunne, Thomas Phelan, William J McCormack, Matthew D Griffin, Alan Kennedy, Alyssa Verrelli, Eamonn Molloy, Declan O'Sullivan, Julie Power, Michael Clarkson, Lina Zgaga, Michelle O'Saughnessy, Mark A Little, Study Protocol for DeCOmPRESS: Defining the Disease Course and Immune Profile of COVID-19 in the Immunosuppressed Patient, HRB Open Res, 4, (6), 2021
Phelan T, Little MA, Brady G., Targeting of the cGAS-STING system by DNA viruses., Biochemical Pharmacology, 174:113831, 2020
Leacy E, Brady G, Little MA., Pathogenesis of ANCA-associated vasculitis: an emerging role for immunometabolism., Rheumatology, 59, (Supplement 3), 2020
David Casserly, Lili Gu, Gareth Brady, Susan Carpenter, Adrian P. Bracken, Katherine A Fitzgerald, Leonie Unterholzner, and Andrew G Bowie., MNDA controls the pathogen-stimulated type I IFN cascade in human monocytes by transcriptional regulation of IRF7., Nature Communications, 2020
Lawler C, Brady G. , Poxviral Targeting of Interferon Regulatory Factor Activation. , Viruses, 12, (10), 2020
Ui Mhaonaigh, A., Coughlan, A. M., Dwivedi, A., Hartnett, J., Cabral, J., Moran, B., Brennan, K., Doyle, S. L., Hughes, K., Lucey, R., Floudas, A., Fearon, U., McGrath, S., Cormican, S., De Bhailis, A., Molloy, E. J., Brady, G., & Little, M. A., Low Density Granulocytes in ANCA Vasculitis Are Heterogenous and Hypo-Responsive to Anti-Myeloperoxidase Antibodies., Frontiers in immunology, 10, (2603), 2019
Dearbhaile Dooley, Mirjan M. van Timmeren, Vincent P. O'Reilly, Gareth Brady, Eoin C. O'Brien, Barbara Fazekas, Fionnuala B. Hickey, Emma Leacy, Charles D. Pusey, Frederick W.K. Tam, Thomas Mehrling, Peter Heeringa and Mark A. Little, Alkylating histone deacetylase inhibitors may have therapeutic value in experimental myeloperoxidase-ANCA vasculitis, Kidney International, 94, (5), 2018, p926 - 993
Brady, G., Haas, D.A., Farrell, P.F., Pichlmair, A. and Bowie, A.G. , Molluscum Contagiosum Virus protein MC005 inhibits NFκB activation by targeting NEMO-regulated IKK activation, The Journal of Virology, 91, (15), 2017, p00545-17
Brady G, Boggan L, Bowie A, O'Neill L.A.J, Erratum: Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1 (The Journal of Biological Chemistry (2005) 280 (30723-30734) DOI: 10.1074/jbc.M500435200), Journal of Biological Chemistry, 291, (48), 2016, p25278-
Brady G, Haas DA, Farrell PJ, Pichlmair A, Bowie AG, Poxvirus Protein MC132 from Molluscum Contagiosum Virus Inhibits NF-B Activation by Targeting p65 for Degradation., Journal of virology, 89, (16), 2015, p8406-15
Brady G, Hass DA, Pichlmair A, Farrell PJ, and Bowie AG. , Human Poxvirus protein MC132 from Molluscum Contagiosum Virus inhibits NFκB activation by targeting p65 for degradation., Journal of Virology , (89), 2015, p8406-15
Brady G and Bowie AG , Poxviral inhibitors of NFκB, Cytokine and Growth Factor Reviews, Oct;25(5), 2014, p611-2
Brady, Gareth Bowie, Andrew G., Innate immune activation of NFκB and its antagonism by poxviruses, Cytokine & Growth Factor Reviews, 2014
Brady G, C.E. Karstegl and P.J. Farrell, Novel function of the unique N terminal region of RUNX1c in B cell growth regulation, Nucleic Acids Research, Feb 1;41(3), 2013, p1555-68
Brady, G., Whiteman, H. J., Spender, L. C., and Farrell, P. J., Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation., Journal of Virology, 83, 2009, p6909 - 6916
Brady, G., and Farrell, P. J., RUNX3-mediated repression of RUNX1 in B cells. , Journal of cellular physiology , 221, 2009, p283-2
Lucchesi, W., Brady, G., Dittrich-Breiholz, O., Kracht, M., Russ, R., and Farrell, P. J., Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. , Journal of virology, 82, 2008, p7456 - 7466
Brady, G., MacArthur, G. J., and Farrell, P. J., Epstein-Barr virus and Burkitt lymphoma., J Clin Pathol., 60(12):13, 2007, p1397-402
Gubster C, Goodbody R, Ecker A, Brady G, O'Neill LA, Jacobs N, Smith GL., Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus, Journal of General Virology, 88, (6), 2007, p1667-1676
Brady G, Boggan L, Bowie A and O'Neill LA, Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1, Journal of Biological Chemistry, 280, (35), 2005, p30723 - 30734
C. Jefferies, A. Bowie, G. Brady, E. L. Cooke, X. Li and L. A. O'Neill, Transactivation by the p65 subunit of NF-kappaB in response to interleukin-1 (IL-1) involves MyD88, IL-1 receptor-associated kinase 1, TRAF-6, and Rac1, Molecular and cellular biology, 21, (14), 2001, p4544-52
Fitzgerald, K. A., Palsson-McDermott, E. M., Bowie, A. G., Jefferies, C. A., Mansell, A. S., Brady, G., Brint, E., Dunne, A., Gray, P., Harte, M. T., McMurray, D., Smith, D. E., Sims, J. E., Bird, T. A., and O'Neill, L. A., Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78-83, Nature, 413, 2001, p73 - 83
Fitzgerald KA, Palsson-McDermott EM, et al, Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction, Nature, 413, (6851), 2001, p78 - 83
Brady, G., Macarthur, G. J., and Farrell, P. J., Epstein-Barr virus and Burkitt lymphoma. , Postgraduate medical Journal, 84, 2008, p372-377
DescriptionMy interests are centered on Viral Immune Evasion, understanding novel aspects of inflammatory signalling and Innate Immunity an the development of Novel anti-inflammatory therapeutics. My research Group the Translational Inflammation Research Group (TIRG) which currently consists of 4 PhD students, two post-doctoral researchers (one currently being hired) a research assistant and a 5-month Spanish Erasmus student. Our SFI-Frontiers funded research focuses on understanding how the human-adapted poxvirus Molluscum Contagiosum Virus evades human immunity and the therapeutic potential of peptides derived from the virus. Our Allergan and SFI-funded COVID research is focused on developing seroassay tools for SARS-CoV to monitor pre- and post-vaccination immune responses in the population in addition to understanding how the virus is detected by and evades the immune system. Our Vasculitis UK funded research focuses on understanding the innate immune signalling of autoantibody-stimulated inflammation in monocytes in an ANCA vasculitis model of disease.
Awards and Honours
National Irish Times Science writing award
Young Investigator Award International RUNX Conference, Ja Jolla, San Diego
Best Research Prize, Irish Society for Immunology (ISI) meeting
Best Research Presentation Prize NF Kappa B 2014 workshop at Pitlochry.
Roche Gold Medal for Best Researcher.
Best Poster Presentation Prize, Irish Society for Immunology (ISI) meeting
Best Basic Science Presentation, Irish Nephrology Society meeting
Allergan Innovation Award 2020
Irish Society of Immunology (also on the Committee, Head of Outreach)